Ace Report Cover
Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients
Reprints
Cite This
Reprints
Cite This
AceReport Image
Metabolic Disorders
Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients
Osteoporos Int. 2016 Jan;27(1):295-9
Contributing Authors

HF Yuan CA Guo ZQ Yan

5 randomized controlled trials investigating the benefits of bisphosphonate therapy in the treatment of femoral head osteonecrosis were included in this meta-analysis. The purpose of this study was to determine whether bisphosphonate treatment should be recommended to patients suffering from this condition. The findings of this report indicated that bisphosphonates did not reduce the progression to joint failure or need for total hip arthroplasty in patients, and did not improve Harris Hip Scores. The results of this trial call into question the use of this treatment for osteonecrosis of the femoral head.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients. ACE Report. 2016;6(6):6. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report